|
[China]
Trade Verify
Address: Rm 505, 1st Building, Shenzhen Biomedicine Innovation Industrial Park, No. 14th, Jinhui Road, East Jinxiu Road, Kengzi Street, Pingshan District, Shenzhen
Contact name:Richard
WWHS Biotech.Inc(exclusive marketed by Dawin) |
|
Verified Suppliers
|
|
|
PGII High Accuracy Tumor Marker Rapid Test Kit WWHS FIA POCT Assay 25T
PGI/PGII Rapid Quantitative Test Human pepsinogens I (PGI) and II
(PGII) are proenzymes of pepsin—an
endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas
PGII is also secreted by the pyloric glands and the proximal duodenal mucosa.
| Name | Loading Capacity | Component |
| Test Card | 25 Persons | The product consists of fluorescent mat (coated with fluorescently-labeled PGII antibody), nitrocellulose membrane (coated with PGII antibody), absorbent paper and PVC soleplate, and so on. |
| Sample Buffer | 25 vials (0.3mL/vial) | Phosphate buffer |
| Information Card | 1 Piece | Record standard curve information of this batch of reagents |
| Tumor Marker | ||||||
| cat#. | Product Item | Specimen | Reaction Time | Measure Range | Clinical Range | Intended Use |
| 20 | AFP | Serum/Plasma | 15min. | 2.5-200ng/ml | <20ng/ml | pregnancy cancer |
| 21 | CEA | Serum/Plasma | 15min. | 1-200ng/ml | <5ng/ml | colon cancer, colorectal cancer,etc. |
| 22 | NSE | Serum/Plasma | 15min. | 1-400ng/ml | <16ng/ml | non-small cell lung cancer |
| 23 | FOB | fecal specimens | 10min. | 50-1000ng/ml | <100ng/ml | Abnormal recessive gastrointestinal bleeding |
| 24 | PG II | Serum/Plasma | 15min. | 1-100ug/L | PGI/PGII>3.0 | gastric abnormalities |
| 25 | PG I | Serum/Plasma | 15min. | 2.5-200ug/L | >70ng/ml | gastric abnormalities |
| 26 | TPSA | Serum/Plasma | 15min. | 0.5-40ng/ml | <4ng/ml | prostate cancer |
| 27 | FPSA | Serum/Plasma | 15min. | 0.1-10ng/ml | <1ng/ml | prostate cancer |
| 28 | CA12-5 | Serum/Plasma | 15min. | 20-500U/ml | <35U/ml | ovarian cancer |
| 29 | CA15-3 | Serum/Plasma | 15min. | 10-400U/ml | < 25 U/mL | breast cancer |
| 30 | HE4 | Serum/Plasma | 15min. | 50-2000pmol/L | <140 pmol/L | ovarian cancer |
| 31 | CA19-9 | Serum/Plasma | 15min. | 10-400U/ml | < 27 U/mL | pancreatic cancer |
| 32 | β-HCG | Serum/Plasma | 15min. | 5-400mIU/ml | <10 mIU/mL | Early pregrancy, ectopic HCG cancer,incomplete abortion |
| 33 | CK19(Cyfra21-1) | Serum/Plasma | 15min. | 0.5-50ng/ml | <2.5ng/ml | non-small cell lung cancer |
Quality Control
A procedural control is included in the test. A colored line
appearing in the control region (C) is the internal procedural
control. It confirms sufficient specimen volume and correct
procedural technique.
Control standards are not supplied with this kit; however, it is
recommended that a positive control and a negative control control
be tested as a good laboratory practice to confirm the test
procedure and to verify proper test performance.
Test Method
1. Please thoroughly read the specification before test. Frozen
test card and sample should be placed at room temperature (15-30) ℃
for at least 30min before use.
2. Start NIR-1000 dry fluoroimmunoassay analyser and verify quality
control according to the specification.
3. The quality of reagent is controlled using internal quality
control product (not provided) of the company and result should be
controllable.
4. Take out the test card from the aluminum foil bag and use it
within 15min
5. Place the test card on a clean horizontal table top and label
it.
6. Take 10μL of sample and add it into HbA1c sample buffer
(1.00mL). Then, mix the solution evenly, take 100μL of the solution
and add it into the well.
7. Insert the test card into NIR-1000 dry fluoroimmunoassay
analyser, keep time for 10min and press 【Instant test】. The
analyser will judge and read the test result automatically. Or
press 【Fixed time test】 to keep time for 10min automatically. The
analyser will judge and read the test result automatically and
display it in the screen.
Applicable Instrument
WWHS NIR-1000 dry fluoroimmunoassay analyser
